News & HighlightsNews
Key mechanism for maintaining proper telomere length identified 
New findings describe how the enzyme CST is recruited to the end of the telomere, where it maintains telomere length with the help of subtle chemical changes made to the protein POT1.
AI could accelerate drug discovery. But only if we can trust it.
The advent of AlphaFold3 could be an unprecedented boon for drug development. Computational biologist Jiankun Lyu discusses the pros and cons of the tech, and his work analyzing the algorithm.
How memories crystallize over time
“Practice makes perfect” is no mere cliché. It's neuroscience.
Researchers may have found an Achilles heel for hepatitis B
New understanding of how the virus replicates could lead to new therapeutic targets for HBV.
Newly discovered brain pathway sheds light on addiction
The findings in mice may explain how addictive drugs hijack natural reward processing systems, creating the urge to use while throwing natural urges to eat and drink off-kilter.
Why some people with rheumatoid arthritis have pain without inflammation
Researchers have identified a suite of genes explaining the disconnect between diagnosis and symptom.
New technique sheds light on memory and learning
The findings may also have implications for learning and memory disorders, including Fragile X syndrome.
Stem cell model offers first glimpse of early human development
The new platform’s ethically grounded approach promises to reveal much about how human embryos form during the earliest stages of pregnancy.
New Mtb study offers a novel paradigm for understanding bacterial transcription
A novel sequencing technique reveals a genetic trick TB may be using to evade the immune system and resist antibiotics.
A pioneering way to target the culprit behind a deadly liver cancer
Researchers have translated a cutting-edge tactic for treating genetic disorders into a fresh approach for potentially stymying cancer.  
View
View